A New Parenteral Emulsion for the Administration of Taxol
- 1 January 1987
- journal article
- research article
- Published by Springer Nature in Pharmaceutical Research
- Vol. 04 (2) , 162-165
- https://doi.org/10.1023/a:1016483406511
Abstract
Taxol (NSC-125973) is a poorly soluble plant product that exhibits excellent antimitotic properties. This study involves the development of a new formulation for taxol. The stability of taxol in a 50% triacetin emulsion as well as possible methods of intravenous administration of this dosage form was examined. A stable emulsion was found at taxol concentrations of 10 and 15 mg/ml of emulsion. The 50% triacetin emulsion showed an intravenous LD50 of 1.2 ml/kg in Swiss-Webster mice. The 10 mg/ml taxol formulation was demonstrated to be stable upon addition to 5% dextrose iv fluids provided that small packing systems were used. The taxol–triacetin emulsion can also be intravenously injected at various rates, and it may prove to be a useful formulation for taxol.This publication has 7 references indexed in Scilit:
- CHRONIC LIPOSOME ADMINISTRATION IN MICE - EFFECTS ON RETICULOENDOTHELIAL FUNCTION AND TISSUE DISTRIBUTION1984
- Taxol: an antimitotic agent with a new mechanism of actionPharmacology & Therapeutics, 1984
- In Vitro Method for Detecting Precipitation of Parenteral Formulations After InjectionJournal of Pharmaceutical Sciences, 1983
- Histamine release and hypotensive reactions in dogs by solubilizing agents and fatty acids: Analysis of various components in cremophor El and development of a compound with reduced toxicityInflammation Research, 1982
- COMPLEMENT-MEDIATED REACTIONS TO DIAZEPAM WITH CREMOPHOR AS SOLVENT (STESOLID MR)British Journal of Anaesthesia, 1980
- Plant antitumor agents. VI. Isolation and structure of taxol, a novel antileukemic and antitumor agent from Taxus brevifoliaJournal of the American Chemical Society, 1971
- Physiology and physiopathology of the reticuloendothelial system.1970